Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-10-01-2012
Volume0
Issue 0

Pharmaceutical Executive Digital Edition - October 2012

Lundbeck's Big Bet

Articles in this issue
Pharmaceutical Executive Digital Edition - October 2012
i1-791505-1408595849194.jpg
PE, October 2012 Cover Image
Lundbeck: Bidding for the Stars and Stripes
Lundbeck: Bidding for the Stars and Stripes
i1-791504-1408595852628.jpg
The Drug Vote 2012
i3_t-791513-1408595824801.jpg
Your Local Competitor: A Threat in Emerging Markets?
i1-791507-1408595843068.jpg
Reforming Pharma Marketing

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million
August 23rd 2025

Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 23rd 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 23rd 2025

Lighthouse Pharmaceuticals Awarded $49.2 Million Grant from NIA to Advance Phase 2 study of LHP588

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 23rd 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
© WESTOCK - © WESTOCK - stock.adobe.com
August 23rd 2025

Supreme Court Upholds NIH Funding Cuts Affecting DEI in Clinical Research

Andy Studna
XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction
August 23rd 2025

XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction

Don Tracy, Associate Editor